drug
sodium zirconium cyclosilicate
Marketedupdated 4mo agoby AstraZeneca Pharmaceuticals LP
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying sodium zirconium cyclosilicate
- phase3An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia
- phase3A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia
- —A National, Multicenter, Prospective, Observational Study to Assess Patient Characteristics, Treatment Algorithms and Disease Management of Hyperkalaemia Patients With Chronic Kidney Disease or Under Dialysis or With Heart Failure, Treated With Sodium Zirconium Cyclosilicate in Greece
- phase4Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study
- phase4Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone
- phase2OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure
- phase3Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)
- phase3A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia.
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 10, 2032
~5.5 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (27)
- Oct 14, 2035compositionUS 10300087
- Oct 14, 2035compositionUS 10300087
- Oct 14, 2035method-of-use (U-2312)US 11738044
- Oct 14, 2035method-of-use (U-2312)US 11738044
- Oct 14, 2035compositionUS 9592253
- Oct 14, 2035compositionUS 9592253
- Oct 22, 2033compositionUS 10695365
- Oct 22, 2033compositionUS 10695365
- Oct 22, 2033compositionUS 8877255
- Oct 22, 2033compositionUS 8877255
- Oct 22, 2033compositionUS 9913860
- Oct 22, 2033compositionUS 9913860
- Apr 19, 2032compositionUS 8802152
- Apr 19, 2032compositionUS 8802152
- Feb 10, 2032method-of-use (U-2312)US 10335432
- Feb 10, 2032method-of-use (U-2312)US 10398730
- Feb 10, 2032method-of-use (U-2312)US 10398730
- Feb 10, 2032compositionUS 10413569
- Feb 10, 2032compositionUS 10413569
- Feb 10, 2032compositionUS 11406662
- Feb 10, 2032compositionUS 11406662
- Feb 10, 2032method-of-use (U-2312)US 8808750
- Feb 10, 2032method-of-use (U-2312)US 8808750
- Feb 10, 2032method-of-use (U-2312)US 9844567
- Feb 10, 2032method-of-use (U-2312)US 9844567
- Feb 10, 2032method-of-use (U-2312)US 9861658
- Feb 10, 2032method-of-use (U-2312)US 9861658
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 28m ago
Found something off?
comments(0)
5-min edit window · permanent after that